These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30572891)

  • 1. Characterizing patient compliance over six months in remote digital trials of Parkinson's and Huntington disease.
    Cohen S; Waks Z; Elm JJ; Gordon MF; Grachev ID; Navon-Perry L; Fine S; Grossman I; Papapetropoulos S; Savola JM
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):138. PubMed ID: 30572891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.
    Lipsmeier F; Taylor KI; Kilchenmann T; Wolf D; Scotland A; Schjodt-Eriksen J; Cheng WY; Fernandez-Garcia I; Siebourg-Polster J; Jin L; Soto J; Verselis L; Boess F; Koller M; Grundman M; Monsch AU; Postuma RB; Ghosh A; Kremer T; Czech C; Gossens C; Lindemann M
    Mov Disord; 2018 Aug; 33(8):1287-1297. PubMed ID: 29701258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.
    Lipsmeier F; Simillion C; Bamdadian A; Tortelli R; Byrne LM; Zhang YP; Wolf D; Smith AV; Czech C; Gossens C; Weydt P; Schobel SA; Rodrigues FB; Wild EJ; Lindemann M
    J Med Internet Res; 2022 Jun; 24(6):e32997. PubMed ID: 35763342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson's disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014).
    Lakshminarayana R; Wang D; Burn D; Chaudhuri KR; Cummins G; Galtrey C; Hellman B; Pal S; Stamford J; Steiger M; Williams A;
    Trials; 2014 Sep; 15():374. PubMed ID: 25257518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and Utility of mHealth for the Remote Monitoring of Parkinson Disease: Ancillary Study of the PD_manager Randomized Controlled Trial.
    Gatsios D; Antonini A; Gentile G; Marcante A; Pellicano C; Macchiusi L; Assogna F; Spalletta G; Gage H; Touray M; Timotijevic L; Hodgkins C; Chondrogiorgi M; Rigas G; Fotiadis DI; Konitsiotis S
    JMIR Mhealth Uhealth; 2020 Jun; 8(6):e16414. PubMed ID: 32442154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study.
    Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C
    Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study.
    Min YH; Lee JW; Shin YW; Jo MW; Sohn G; Lee JH; Lee G; Jung KH; Sung J; Ko BS; Yu JH; Kim HJ; Son BH; Ahn SH
    J Med Internet Res; 2014 May; 16(5):e135. PubMed ID: 24860070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The STEPWISE study: study protocol for a smartphone-based exercise solution for people with Parkinson's Disease (randomized controlled trial).
    Schootemeijer S; de Vries NM; Macklin EA; Roes KCB; Joosten H; Omberg L; Ascherio A; Schwarzschild MA; Bloem BR
    BMC Neurol; 2023 Sep; 23(1):323. PubMed ID: 37700241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition, function and awareness of disease impact in early Parkinson's and Huntington's disease.
    Júlio F; Ribeiro MJ; Morgadinho A; Sousa M; van Asselen M; Simões MR; Castelo-Branco M; Januário C
    Disabil Rehabil; 2022 Mar; 44(6):921-939. PubMed ID: 32620060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD).
    Schneider RB; Omberg L; Macklin EA; Daeschler M; Bataille L; Anthwal S; Myers TL; Baloga E; Duquette S; Snyder P; Amodeo K; Tarolli CG; Adams JL; Callahan KF; Gottesman J; Kopil CM; Lungu C; Ascherio A; Beck JC; Biglan K; Espay AJ; Tanner C; Oakes D; Shoulson I; Novak D; Kayson E; Ray Dorsey E; Mangravite L; Schwarzschild MA; Simuni T;
    Ann Clin Transl Neurol; 2021 Feb; 8(2):308-320. PubMed ID: 33350601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive flexibility and complex integration in Parkinson's disease, Huntington's disease, and schizophrenia.
    Hanes KR; Andrewes DG; Pantelis C
    J Int Neuropsychol Soc; 1995 Nov; 1(6):545-53. PubMed ID: 9375241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GEORGE®: A Pilot Study of a Smartphone Application for Huntington's Disease.
    Waddell EM; Dinesh K; Spear KL; Elson MJ; Wagner E; Curtis MJ; Mitten DJ; Tarolli CG; Sharma G; Dorsey ER; Adams JL
    J Huntingtons Dis; 2021; 10(2):293-301. PubMed ID: 33814455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease.
    Lipsmeier F; Taylor KI; Postuma RB; Volkova-Volkmar E; Kilchenmann T; Mollenhauer B; Bamdadian A; Popp WL; Cheng WY; Zhang YP; Wolf D; Schjodt-Eriksen J; Boulay A; Svoboda H; Zago W; Pagano G; Lindemann M
    Sci Rep; 2022 Jul; 12(1):12081. PubMed ID: 35840753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study.
    Arora S; Venkataraman V; Zhan A; Donohue S; Biglan KM; Dorsey ER; Little MA
    Parkinsonism Relat Disord; 2015 Jun; 21(6):650-3. PubMed ID: 25819808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying Parkinson's disease severity using mobile wearable devices and machine learning: the ParkApp pilot study protocol.
    Ymeri G; Salvi D; Olsson CM; Wassenburg MV; Tsanas A; Svenningsson P
    BMJ Open; 2023 Dec; 13(12):e077766. PubMed ID: 38154904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale Wearable Sensor Deployment in Parkinson's Patients: The Parkinson@Home Study Protocol.
    Silva de Lima AL; Hahn T; de Vries NM; Cohen E; Bataille L; Little MA; Baldus H; Bloem BR; Faber MJ
    JMIR Res Protoc; 2016 Aug; 5(3):e172. PubMed ID: 27565186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associative learning in degenerative neostriatal disorders: contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases.
    Sprengelmeyer R; Canavan AG; Lange HW; Hömberg V
    Mov Disord; 1995 Jan; 10(1):51-65. PubMed ID: 7885356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial.
    van der Kolk NM; de Vries NM; Kessels RPC; Joosten H; Zwinderman AH; Post B; Bloem BR
    Lancet Neurol; 2019 Nov; 18(11):998-1008. PubMed ID: 31521532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.